RKTO
NASD Rocket One Inc.$0.5070 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.5070, $0.0428 below the day’s high of $0.5498
- YTD change
- -70.18%
- vs 20-day SMA
- -26.47%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-1.19 (-70.18%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 79.3% away from all-time highs of $2.4500
- RKTO is down 70% since the beginning of the year
- RKTO is down 70% over the past 12 months
- RKTO is down 36% over the past 1 month
- 4% of all RKTO investors are betting against RKTO
RKTO reads poor: the 12-month move is -70.2%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0101
- Last 5 days
- -21.53%
- vs 8-day SMA
- -17.35%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Rocket One, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in Hoboken, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.